πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors β€” phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β€” searchable for business development and competitive intelligence.

1,146 results for β€œYung” Clear

  1. Oral carbohydrate (Outfast)

    The First People's Hospital of Lianyungang

    Gastrointestinal Surgery

    other completed

    1 trial
  2. PCSK9 inhibitor

    The First People's Hospital of Lianyungang

    Intracranial Artery Stenosis

    small molecule active

    1 trial
  3. PD1-BCMA-CART

    The First People's Hospital of Lianyungang

    Multiple Myeloma

    mab active

    1 trial
  4. PEG-rhG-CSF

    The First People's Hospital of Lianyungang

    Lymphoma

    small molecule active

    1 trial
  5. PIMS screening

    The First People's Hospital of Lianyungang

    PGT-A

    gene therapy active

    1 trial
  6. PSMA PET/CT

    The First People's Hospital of Lianyungang

    Prostate Adenocarcinoma

    other active

    1 trial
  7. PSMA PET/MRI-TRUS guided prostate targeted combined saturation biopsy

    The First People's Hospital of Lianyungang

    Prostate Cancer Screening

    other active

    1 trial
  8. Paclitaxel oral solution plus Subcutaneous Pertuzumab/Trastuzumab

    The First People's Hospital of Lianyungang

    Breast Cancers

    small molecule active

    1 trial
  9. Peak value anti-Xa

    The First People's Hospital of Lianyungang

    Venous Thromboembolism

    other active

    1 trial
  10. Peginterferon Ξ±-2b injection

    The First People's Hospital of Lianyungang

    Condylomata Acuminata

    small molecule active

    1 trial
  11. Peginterferon Ξ±-2b plus an anti-PD-1

    The First People's Hospital of Lianyungang

    Advanced Solid Tumors

    small molecule active

    1 trial
  12. Percutaneous transhepatic biliary stenting with conventional linear ^125^I seeds strand

    The First People's Hospital of Lianyungang

    Malignant Obstructive Jaundice

    other completed

    1 trial
  13. Personalized mRNA Tumor Vaccine

    The First People's Hospital of Lianyungang

    Esophageal Cancer

    mab active

    1 trial
  14. Prebiotic Fiber Supplement + loperamide hydrochloride capsule

    The First People's Hospital of Lianyungang

    Chemotherapy-related Diarrhea

    other terminated

    1 trial
  15. Prediction Model Arm

    The First People's Hospital of Lianyungang

    Lung Cancer Screening

    other active

    1 trial
  16. Prediction of intraoperative hypothermia risk

    The First People's Hospital of Lianyungang

    Intraoperative Hypothermia

    other completed

    1 trial
  17. Prednisolone

    The First People's Hospital of Lianyungang

    HIV (Human Immunodeficiency Virus)

    small molecule active

    1 trial
  18. Prostate biopsy guided by PSMA PET/CT

    The First People's Hospital of Lianyungang

    PSMA PET/CT

    other active

    1 trial
  19. Protocol-based management of perioperative antithrombotic therapy

    The First People's Hospital of Lianyungang

    Antithrombotic Therapy

    small molecule active

    1 trial
  20. Pueraria lobata radix

    The First People's Hospital of Lianyungang

    Type 2 Diabetes Mellitus

    small molecule active

    1 trial
  21. Qingre Huashi Granules combined the modified dual therapy

    The First People's Hospital of Lianyungang

    Helicobacter Pylori Infection

    small molecule active

    1 trial
  22. R-CDOP

    The First People's Hospital of Lianyungang

    Diffuse Large B Cell Lymphoma

    other active

    1 trial
  23. RB001

    The First People's Hospital of Lianyungang

    Phelan-McDermid Syndrome

    gene therapy active

    1 trial
  24. Regional lymph node radiotherapy (RNI) including the axilla

    The First People's Hospital of Lianyungang

    Axillary Lymph Node Dissection

    other active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β€” verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources